UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000023149 |
|---|---|
| Receipt number | R000026630 |
| Scientific Title | A Phase Ib/II Study of BBI608 in Combination with Pembrolizumab in Patients with Metastatic Colorectal Cancer |
| Date of disclosure of the study information | 2016/09/13 |
| Last modified on | 2021/03/18 10:33:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/07/13 14:02:08 | ||
| 2 | Update | 2016/08/04 15:14:38 | Date of disclosure of the study information |
|
| 3 | Update | 2016/10/20 11:45:32 | Recruitment status Anticipated trial start date |
|
| 4 | Update | 2017/04/06 10:19:55 | Institutions |
|
| 5 | Update | 2017/04/06 10:24:50 | Recruitment status |
|
| 6 | Update | 2018/07/17 08:58:24 | Recruitment status Last follow-up date |
|
| 7 | Update | 2019/11/14 14:44:16 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 8 | Update | 2019/11/14 14:57:55 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria Target sample size |
|
| 9 | Update | 2020/01/14 10:18:10 | Date of IRB Last follow-up date |
|
| 10 | Update | 2020/07/16 09:55:31 | Last follow-up date |
|
| 11 | Update | 2021/03/18 10:33:25 | Recruitment status Last follow-up date |
